Singh Jasvinder MDDr. Singh is a Professor in the Division of Rheumatology and Clinical Immunology. The primary goal of Dr. Singh’s research is to improve the outcomes of patients with arthritis and rheumatic conditions. The objectives of Dr. Singh’s research program are, (1) to advance evidence-based medicine by performing state-of-the-art Cochrane Systematic Reviews, Meta-analyses and Network Meta-analyses as well as the development and dissemination of treatment guidelines that can change the way we provide the best care to patients with rheumatic conditions, and (2) to improve our understanding of what impacts poor patient outcomes, including pain and function in arthritis, and design interventions to improve these outcomes.

Brent Carter MDDr. Carter is a Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine. The primary goal of Dr. Carter's research is to understand the molecular mechanisms that modulate the development of lung injury and pulmonary fibrosis. Specifically, his laboratory focuses on the role of macrophage phenotype, macrophage-derived oxidant production, mitochondrial metabolism, and signaling in the pathogenesis of pulmonary fibrosis.

Hsh phdDr. Hui-Chen Hsu is Associate Professor of Medicine in the Division of Clinical Immunology and Rheumatology. Dr. Hsu collaborated with Drs. John D. Mountz, Hao Li, Jun Li, Yong Zhou, David Crossman, Janusz H. Kabarowski and several other leading investigators in the field and made the seminal discovery on a novel pathogenic role of type I interferon (IFN) in promoting systemic lupus erythematosus (SLE), a challenging autoimmune disease without a cure. The work stemmed from Dr. Hsu’s research which focuses on how elevated type I IFNs produced by plasmacytoid dendritic cells (pDCs) in the spleen marginal zone can induce follicular translocation of marginal zone (MZ) B cells.

Timmy Lee MDTimmy Lee, MD, MSPH, is Associate Professor of Medicine in the Division of Nephrology and Staff Nephrologist at the Birmingham Veterans Affairs Medical Center. He is the Associate Director of Interventional Nephrology, Director of Hemodialysis at the Birmingham Veterans Affairs Medical Center, and Associate Fellowship Director of UAB Nephrology Fellowship Program. He also currently serves as a Councilor for the American Society of Diagnostic and Interventional Nephrology.

Virginia Wadley Bradley, PhD
Dr. Wadley Bradley is a licensed medical/clinical psychologist and Associate Professor of Medicine within the Division of Gerontology, Geriatrics, and Palliative Care. She is also Director of the Dementia Care Research Program of the Comprehensive Center for Healthy Aging

Dr. Anthony DiStasi
Dr. Di Stasi is Assistant Professor of Medicine in the Bone Marrow Transplantation and Cell Therapy Program Unit, where he performs both clinical and translational research activities. His primary research focus involves the pre-clinical validation of adoptive T cell immunotherapy strategies for hematologic malignancies.